# Internal Review Round 1

**Date:** 2026-03-09
**Reviewer:** Claude Code (self-review as Reviewer 2)
**Verdict:** Minor Revision

## Summary

Strong paper with a clear narrative: TWFE bias flips the sign of estimated treatment effect for selective licensing in England. The CS-DiD methodology is correctly implemented. The paper is well-structured and the key finding (TWFE vs CS-DiD divergence) is both novel and policy-relevant.

## Strengths

1. **Clean identification**: 52 treated LAs with staggered adoption over 17 years, large never-treated comparison group (352 LAs), and 24M transactions provide excellent statistical power.
2. **Methodological rigor**: Implements CS-DiD, Sun-Abraham, RI, leave-one-out, and multiple time windows. Event study supports parallel trends.
3. **Clear narrative**: The TWFE-to-CS-DiD sign reversal is a compelling headline finding.
4. **Dose-response heterogeneity**: The PRS share interaction provides mechanism evidence.

## Concerns

### Major
1. The main text is exactly at the 25-page threshold. Some sections could benefit from more depth, particularly the mechanisms discussion.
2. The Bacon decomposition failed due to unbalanced panel — should be noted in the paper rather than silently omitted.

### Minor
1. The hedonic model (transaction-level) was not estimated due to a parquet read error. This should be noted as a limitation.
2. Abstract mentions "24 million" transactions but the main analysis uses the aggregated LA-year panel (7,188 obs). Clarify.
3. Some figures may have small text — verify readability at standard zoom.

## Recommendation

Proceed to advisor review with minor revisions addressing the concerns above.
